Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119429 · ClinicalTrials.gov registry record · Phase 2
Pumpkin Seed Oil Supplementation in Premenopausal Women
A Phase 2 study, sponsored by Texas Woman's University.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT02119429 is a Phase 2 study that has completed, run by Texas Woman's University. The registered enrollment target is 50 participants.
The verdict
NCT02119429, a Phase 2 study, has completed, sponsored by Texas Woman's University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether or not there is an effect of pumpkin seed oil supplementation, 2 grams per day, on blood pressure (systolic and diastolic) in premenopausal women.
Interventions
- DIETARY_SUPPLEMENT Pumpkin Seed Oil
- DIETARY_SUPPLEMENT Wheat Germ Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02119429
The ClinicalTrials.gov registry entry for NCT02119429 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Woman's University, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pumpkin Seed Oil is the first listed.
NCT02119429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02119429 about?
NCT02119429 is a clinical study titled "Pumpkin Seed Oil Supplementation in Premenopausal Women". The purpose of this study is to determine whether or not there is an effect of pumpkin seed oil supplementation, 2 grams per day, on blood pressure (systolic and diastolic) in premenopausal women.
What is the current status of trial NCT02119429?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2014-04. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02119429?
The interventions under investigation include: Pumpkin Seed Oil (DIETARY_SUPPLEMENT), Wheat Germ Oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02119429?
This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.